AI-generated summary
This evidence map reviewed systematic reviews of photobiomodulation for oral facial pain and graphically displayed the parameters analyzed. The authors report that a positive effect was found in 61.4% of studies, but the impact degree was rated low in 60.2% by the AMSTAR 2 quality tool. They conclude that complete dosimetry information is still lacking, making the results difficult to reproduce.
- Who or what was studied
- Oral facial pain in diseases of the oral cavity
- Limits stated in the abstract
- The abstract notes that complete dosimetry information is lacking in published PBM studies, which makes results difficult to reproduce, and that most included reviews were rated low on AMSTAR 2.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Dosimetry. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.